REG - EKF Diagnostics Hldg - Result of AGM and Voting Results

EKF Diagnostics HoldingsAnnouncement

14/05/2024 13:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240514:nRSN3987Oa&default-theme=true

RNS Number : 3987O  EKF Diagnostics Holdings PLC  14 May 2024

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Result of AGM and Voting Results

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics
business, announces that at its Annual General Meeting ("AGM") held earlier
today, all resolutions were duly passed.

 

The voting results of the AGM were as follows:

 

             For                     Against               Withheld
 Resolution  Votes          %        Votes         %       Votes
 1            248,228,094   99.78%    547,604      0.22%    58,727,253
 2            306,929,202   99.99%    17,611       0.01%    556,138
 3            307,478,974   100.00%   13,855       0.00%    10,122
 4            242,675,522   97.55%    6,098,796    2.45%    58,728,633
 5            307,473,521   99.99%    19,308       0.01%    10,122
 6            307,471,021   99.99%    21,808       0.01%    10,122
 7            302,901,784   98.51%    4,594,167    1.49%    7,000
 8            307,478,340   99.99%    16,355       0.01%    8,256
 9            307,474,469   99.99%    16,029       0.01%    12,453
 10*          305,495,468   99.35%    1,998,483    0.65%    9,000
 11*          251,801,517   81.89%    55,692,434   18.11%   9,000
 12*          247,115,598   83.20%    49,902,353   16.80%   10,485,000

 

*Special Resolutions

 

 EKF Diagnostics Holdings plc                               www.ekfdiagnostics.com (http://www.ekfdiagnostics.com)
 Julian Baines, Executive Chair / Stephen Young, CFO         via Walbrook PR

 Singer Capital Markets (Nominated Adviser & Broker)                                      Tel: +44 (0)20 7496 3000
 Aubrey Powell / Oliver Platts

 Walbrook PR Limited            Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com (mailto:ekf@walbrookpr.com)
 Paul McManus / Alice Woodings  Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com
(http://www.ekfdiagnostics.com) )

 

EKF is an AIM-listed global diagnostics business focussed on:

 

 ●    Point-of-Care analysers in the key areas of Hematology and Diabetes

 ●    Life Sciences services provide specialist manufacture of enzymes and custom
      products for use in diagnostic, food and industrial applications.

 

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing
sites across the US and Germany, selling into over 120 countries world-wide.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGQKQBDBBKDQPD